LORATADINE AND PSEUDOEPHEDRINE SULFATE- loratadine and pseudoephedrine sulfate tablet, film coated, extended release 
REMEDYREPACK INC.

----------

Drug Facts

OTC - ACTIVE INGREDIENT

Loratadine, USP 10 mg

Pseudoephedrine sulfate, USP 240 mg

 

OTC - PURPOSE

Antihistamine

Nasal decongestant

 

INDICATIONS & USAGE

  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
    • sneezing
    • itchy, watery eyes
    • runny nose
    • itching of the nose or throat
  • reduces swelling of nasal passages
  • temporarily relieves sinus congestion and pressure
  • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
  • temporarily restores freer breathing through the nose

 

WARNINGS

  • if you have ever had an allergic reaction to this product or any of its ingredients
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

 

  • heart disease
  • thyroid disease
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • liver or kidney disease. Your doctor should determine if you need a different dose.

 

Taking more than directed may cause drowsiness.

 

  • an allergic reaction to this product occurs. Seek medical help right away.
  • symptoms do not improve within 7 days or are accompanied by a fever
  • nervousness, dizziness or sleeplessness occurs

 

ask a health professional before use.

 

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

 

DOSAGE & ADMINISTRATION

  • do not divide, crush, chew or dissolve the tablet
adults and children 12 years and over1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours
children under 12 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

 

SPL UNCLASSIFIED

  • sodium: contains 10 mg/tablet
  • calcium: contains 25 mg/tablet
  • TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL IS BROKEN OR MISSING FROM BOTTLE. (for bottle cartons/labels only)
  • TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING. (for blister cartons only)
  • store between 20° C to 25° C (68° F to 77° F).
  • protect from light and store in a dry place

 

INACTIVE INGREDIENT

calcium carbonate, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, shellac glaze, sodium alginate, sodium citrate, talc and titanium dioxide

 

OTC - QUESTIONS

call 1-800-406-7984

Keep the carton. It contains important information.

See end panel for expiration date.

Distributed By

MAJOR PHARMACEUTICALS

31778 Enterprise Drive, LIVONIA,

MI 48150, USA

 

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

DRUG: Loratadine and Pseudoephedrine Sulfate


GENERIC: Loratadine and Pseudoephedrine Sulfate


DOSAGE: TABLET, FILM COATED, EXTENDED RELEASE


ADMINSTRATION: ORAL


NDC: 61786-143-57


ACTIVE INGREDIENT(S):

  • LORATADINE 10mg in 1
  • PSEUDOEPHEDRINE SULFATE 240mg in 1


INACTIVE INGREDIENT(S):

  • CALCIUM CARBONATE
  • PROPYLENE GLYCOL
  • SHELLAC
  • STARCH, PREGELATINIZED CORN
  • POVIDONE
  • TALC
  • SODIUM ALGINATE
  • SODIUM CITRATE
  • POLYETHYLENE GLYCOLS
  • CELLULOSE, MICROCRYSTALLINE
  • HYDROXYPROPYL CELLULOSE
  • COLLOIDAL SILICON DIOXIDE
  • HYPROMELLOSES
  • FERROSOFERRIC OXIDE
  • MAGNESIUM STEARATE
  • LACTOSE MONOHYDRATE
  • TITANIUM DIOXIDE


COLOR: white


SHAPE: CAPSULE


SCORE: No score


SIZE: 17 mm


IMPRINT: RX724


PACKAGING: 5 in 1 BOTTLE




MM1

MM2

LORATADINE AND PSEUDOEPHEDRINE SULFATE 
loratadine and pseudoephedrine sulfate tablet, film coated, extended release
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61786-143(NDC:0904-5833)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
PSEUDOEPHEDRINE SULFATE (UNII: Y9DL7QPE6B) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE SULFATE240 mg
Inactive Ingredients
Ingredient NameStrength
CALCIUM CARBONATE (UNII: H0G9379FGK)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SHELLAC (UNII: 46N107B71O)  
STARCH, PREGELATINIZED CORN (UNII: O8232NY3SJ)  
POVIDONE (UNII: FZ989GH94E)  
TALC (UNII: 7SEV7J4R1U)  
SODIUM ALGINATE (UNII: C269C4G2ZQ)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
HYDROXYPROPYL CELLULOSE (TYPE H) (UNII: RFW2ET671P)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorwhiteScoreno score
ShapeCAPSULE (TABLET, FILM COATED, EXTENDED RELEASE) Size17mm
FlavorImprint Code RX724
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:61786-143-575 in 1 BOTTLE; Type 0: Not a Combination Product01/14/201504/16/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07655701/14/201504/16/2016
Labeler - REMEDYREPACK INC. (829572556)

Revised: 3/2017
 
REMEDYREPACK INC.